World Health Organization looks ahead to life without the US
LONDON/GENEVA (Reuters) -Hundreds of officials from the World Health Organization will join donors and diplomats in Geneva from Monday with one question dominating their thoughts - how to cope with crises from mpox to cholera without their main funder, the United States.
The annual assembly, with its week of sessions, votes and policy decisions, usually showcases the scale of the U.N. agency set up to tackle disease outbreaks, approve vaccines and support health systems worldwide.
This year - since U.S. President Donald Trump started the year-long process to leave the WHO with an executive order on his first day in office in January - the main theme is scaling down.
"Our goal is to focus on the high-value stuff," Daniel Thornton, the WHO's director of coordinated resource mobilisation, told Reuters.
Just what that "high-value stuff" will be is up for discussion. Health officials have said the WHO's work in providing guidelines for countries on new vaccines and treatments for conditions from obesity to HIV will remain a priority.
One WHO slideshow for the event, shared with donors and seen by Reuters, suggested work on approving new medicines and responding to outbreaks would be protected, while training programmes and offices in wealthier countries could be closed.
The United States had provided around 18% of the WHO's funding. "We've got to make do with what we have," said one Western diplomat who asked not to be named.
Staff have been getting ready - cutting managers and budgets - ever since Trump's January announcement in a rush of directives and aid cuts that have disrupted a string of multilateral pacts and initiatives.
The year-long delay, mandated under U.S. law, means the U.S. is still a WHO member - its flag still flies outside the Geneva HQ - until its official departure date on January 21, 2026.
Trump - who accused the WHO of mishandling COVID, which it denies - muddied the waters days after his statement by saying he might consider rejoining the agency if its staff "clean it up".
But global health envoys say there has since been little sign of a change of heart. So the WHO is planning for life with a $600 million hole in the budget for this year and cuts of 21% over the next two-year period.
CHINA TAKES LEAD
As the United States prepares to exit, China is set to become the biggest provider of state fees - one of the WHO's main streams of funding alongside donations.
China's contribution will rise from just over 15% to 20% of the total state fee pot under an overhaul of the funding system agreed in 2022.
"We have to adapt ourselves to multilateral organisations without the Americans. Life goes on," Chen Xu, China's ambassador to Geneva, told reporters last month.
Others have suggested this might be a time for an even broader overhaul, rather than continuity under a reshuffled hierarchy of backers.
"Does WHO need all its committees? Does it need to be publishing thousands of publications each year?' said Anil Soni, chief executive of the WHO Foundation, an independent fund-raising body for the agency.
He said the changes had prompted a re-examination of the agency's operations, including whether it should be focussed on details like purchasing petrol during emergencies.
There was also the urgent need to make sure key projects do not collapse during the immediate cash crisis. That meant going to donors with particular interests in those areas, including pharmaceutical companies and philanthropic groups, Soni said.
The ELMA Foundation, which focuses on children's health in Africa with offices in the U.S., South Africa and Uganda, has already recently stepped in with $2 million for the Global Measles and Rubella Laboratory Network known as Gremlin - more than 700 labs which track infectious disease threats, he added.
Other business at the assembly includes the rubber-stamping a historic agreement on how to handle future pandemics and drumming up more cash from donors at an investment round.
But the focus will remain on funding under the new world order. In the run up to the event, a WHO manager sent an email to staff asking them to volunteer, without extra pay, as ushers.
(Additional reporting by Olivia Le Poidevin; Editing by Andrew Heavens)
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Associated Press
23 minutes ago
- Associated Press
Sethera Therapeutics Unveils Breakthrough Enzymatic Platform for Next-Generation Peptide Drugs
Salt Lake City, Utah--(Newsfile Corp. - August 21, 2025) - Sethera Therapeutics today announced publication in the Proceedings of the National Academy of Sciences (PNAS) of peer-reviewed results describing an enzymatic crosslinking platform that forges durable thioether 'staples,' locking peptides into drug-like cyclic architectures. The platform works across a broad range of substrates, including sequences built entirely from non-natural building blocks, delivering exceptional versatility, expanding accessible chemical space, and enabling the design of next-generation peptide therapeutics. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: [ This image cannot be displayed. Please visit the source: ] Click image above to view full announcement. About Sethera Therapeutics Sethera Therapeutics is developing internal programs and collaborations that leverage its enzymatic macrocyclization platform to create more effective, stable, and deliverable peptide medicines. By opening vast new design space and offering precise architectural control, Sethera is positioned to help lead the next wave of innovation in peptide therapeutics. Contacts: Karsten Eastman, PhD, CEO 385-461-8528 [email protected] Source: Sethera Therapeutics To view the source version of this press release, please visit

Associated Press
23 minutes ago
- Associated Press
A Hair Transplant Journey Starting in the UK, Completed in Turkey
ISTANBUL, TURKEY / ACCESS Newswire / August 21, 2025 / Established in Turkey, Esteworld now offers face-to-face consultations in London and continues its operations in its state-of-the-art hospitals in Istanbul. This combines clinical quality with the value that has made Turkey a global destination. Post-procedure care is provided in the country where the procedure was performed. August 20, 2025 Esteworld announced the launch of a new office in London, marking the next step in the brand's international growth. Having built its reputation by delivering hair transplant in Turkey services, Esteworld is expanding access for UK and European patients who want local guidance before and after surgery, with the procedure itself performed by experienced teams in Istanbul. 'Patients told us they want two things: the clinical excellence and value associated with Turkey, and the convenience of a local touchpoint,' said an Esteworld spokesperson. 'Our London office brings those together. People can receive assessments, treatment planning, and follow-ups close to home, while their surgical journey remains anchored in our established Turkish hospitals.' A seamless UK-Turkey care pathway The London location is designed for consultations (not surgical procedures) so patients can meet a medical consultant, discuss candidacy, choose the most suitable hair transplant method, and understand the expected timeline before traveling. This model makes the experience more accessible for patients who prefer face-to-face guidance without sacrificing the standards and efficiencies that Turkey offers. A great opportunity for those who cannot have a hair transplant in London. In Istanbul, Esteworld performs procedures such as FUE (Follicular Unit Extraction), Sapphire FUE, DHI (Direct Hair Implantation), and unshaven approaches for qualifying candidates. Technique recommendations are individualized, taking into account donor density, hair caliber, curl pattern, hairline design goals, and long-term planning to maintain a natural look as hair loss progresses. About Esteworld Established in 1994, Esteworld is an international healthcare group specializing in hair transplantation, plastic surgery, medical aesthetics, and dental aesthetics. With a network spanning 35+ countries, Esteworld delivers end-to-end patient pathways through coordinated local offices and advanced hospital facilities. Esteworld's hair restoration portfolio includes FUE, Sapphire FUE, DHI, and suitable unshaven approaches, supported by standardized clinical protocols, donor management strategies, and natural hairline design principles. Multilingual patient coordination, transparent pricing structures, and comprehensive post-operative follow-up are integral to the group's service model. Combining high surgical experience with evidence-based practice and rigorous safety standards, Esteworld focuses on outcomes that look natural and remain sustainable over time. The group's integrated approach aligns medical necessity with aesthetic goals, providing patients a reliable, seamless, and internationally accessible care experience. Why Turkey remains a leader in hair transplantation Turkey's prominence in hair restoration stems from high surgical volumes, specialized teams, and a service model that streamlines logistics for international patients. Many clinics (Esteworld included also) organize airport transfers, translation assistance, and post-operative kits to reduce friction during a short medical stay. The combination of experience, coordinated care, and competitive pricing has drawn patients from around the world. About hair transplant prices in Turkey While pricing always depends on the clinic, technique, surgeon seniority, and graft count, Turkey is widely recognized for cost-effective options compared with Western Europe and North America. Patients commonly encounter two pricing structures: Because individual needs differ (some require 2,000 grafts, others 4,000 or more) final costs are best determined after a professional evaluation that considers donor capacity and long-term hair-loss patterns. Esteworld emphasizes transparent quoting so patients understand exactly what is included before traveling. What patients can expect with Esteworld Consultation & candidacy: At the London office, patients receive a structured assessment that reviews medical history, scalp condition, and donor area. The consultant discusses realistic outcomes, hairline philosophy, and potential graft counts, and sets expectations around the growth timeline. Technique selection: FUE and DHI are the most frequently recommended techniques. FUE involves extracting follicular units individually and implanting them into micro-channels; Sapphire FUE uses sapphire-tipped tools for channel creation; DHI places grafts with pen-like instruments that allow precise angle and direction. The goal is to harmonize density, direction, and hairline shape with each patient's unique features. Surgery in Istanbul: Procedures are performed by dedicated teams in Esteworld's Turkish hospitals, where standardized protocols govern anesthesia, sterile technique, graft handling, and recipient site creation. High case volumes help refine micro-surgical skills and consistency, supporting natural, age-appropriate results. Safety, ethics, and realistic expectations Hair transplantation is a medical procedure, not a commodity. Esteworld advocates for evidence-based practice and thorough informed consent. Not every patient is an ideal candidate. Donor limitations, diffuse thinning, scarring alopecia, or certain medical conditions may call for conservative plans or a staged approach. Adjunct therapies (including topical agents, oral medications when appropriate, low-level laser therapy, and PRP) may be discussed as part of a personalized long-term strategy. A natural outcome depends on more than graft numbers. Key variables include the hairline's anatomic placement, graft angulation, distribution in zones of visual priority, and respect for future hair-loss progression. Esteworld's planning process prioritizes long-term aesthetics to avoid an unnaturally dense front with inadequate reserves for later. The patient journey, step by step Value without compromise By originating in Turkey and later opening a London office, Esteworld aims to combine the best of both worlds: the experience and efficiencies that come from a leading hair transplant Turkey ecosystem, and the reassurance of local, ongoing support. For many, this hybrid model shortens decision time, clarifies expectations, and maintains continuity from first conversation to final results. 'Patients deserve clarity,' the Esteworld spokesperson added. 'Our approach is to explain the medical reasoning, set goals that make sense for the long term, and deliver attentive aftercare. Opening in London lets us do even more of that, face-to-face.' Media Details : Name: Burak Tuncer E-mail: [email protected] Phone number: +90 216 474 54 54 Web: SOURCE: Burak Tuncer press release

Associated Press
23 minutes ago
- Associated Press
Jessica Stangenwald Joins Women in Power TV to Share Her Vision for Transforming Healthcare
FL, UNITED STATES, August 21, 2025 / / -- Jessica Stangenwald, founder of The Vital Reset, is set to appear on Women in Power TV, where she shares how her unwavering commitment to health and wellness drives her mission to empower others. Women in Power is a cinematic docu-series that celebrates visionary women who are rewriting the rules of success. Hosted by Rudy Mawer, the show dives deep into each guest's story—from struggle to triumph—highlighting the courage and conviction behind their success. You can find out more about the show by visiting their website. In her episode, Stangenwald explores the importance of guiding people toward true healthcare, not just symptom management, and breaks down how education and functional medicine can drive lasting change. 'My passion is to help people understand their body's potential and take control of their health,' said Stangenwald. Jessica's episode will be available soon on Inside Success Network, streaming on popular platforms. In the meantime, you can find out more by visiting Jessica Stangenwald Women in Power email us here Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.